Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (CabOSTar)
The participants of this study will be children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery.
Participants will have achieved a partial response or stable disease at the end of…
- Investigator
- Joanne Lagmay
- Status
- Accepting Candidates
- Ages
- 5 Years - 30 Years
- Sexes
- All
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles…
- Investigator
- Joanne Lagmay
- Status
- Accepting Candidates
- Ages
- 12 Months - 21 Years
- Sexes
- All
Neuroblastoma Maintenance Therapy Trial (NMTT)
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 ±…
- Investigator
- Joanne Lagmay
- Status
- Accepting Candidates
- Ages
- 1 Year - 30 Years
- Sexes
- All